Overexpression of EHMT2 has been observed in various cancers including esophageal squamous cell carcinoma, aggressive lung cancer, multiple myeloma, brain cancer, ovarian carcinoma, etc. [26–28]. This evidence concerns the gene EHMT2 and brain cancer.